The coronaVac vaccine, from the Chinese pharmaceutical company Sinovac, arrived in Mexico today to become the third dose available in the country. According to the Ministry of Health, the vaccine It will be applied in older adults of the 200 urban municipalities with the highest mortality from covid-19, which is intended to reduce hospitalization cases by up to 78 percent among those infected and 91 percent to prevent the disease.
The drug from Sinovac Biotech Ltd., a Chinese biopharmaceutical company based in Beijing, has an overall efficacy of 50.4 percent in end-stage trials in Brazil, so the experts considered that this result is “good enough considering that almost all trial participants in Brazil were high-risk medical workers”.
While, in cases considered mild of contagion, increases its effectiveness up to 77.96 percent, with which the specialists affirmed that this “protection means the vaccine will reduce the number of people needing hospitalization by 78 percent”.
From China to the world
Turkey’s Health Minister Fahrettin Koca received the first dose of the CoronaVac vaccine on January 13, becoming the first person in Turkey to receive the vaccine.
The next day, the president of that country, Tayyip Erdogan, also received his first dose. In a month of vaccination, more than 250,000 Turks have been immunized.
More than 10 countries have purchased vaccines from Sinovac, including: Turkey, Philippines, Indonesia, Brazil, Chile, France, United Kingdom, Italy and Germany.
European countries, such as Ukraine, have made the purchase of CoronaVac, where previous weeks have already signed an agreement with the Chinese pharmaceutical company for the purchase of 5 million doses of such a vaccine, which became the sole supplier to Ukraine so far.
Just on February 19, Foreign Minister Marcelo Ebrard announced that in addition to the 200 thousand doses that arrived in our country, hundreds of batches are expected that will contain 10 million more doses.
In that sense, he thanked the invaluable support of the Ambassador of the People’s Republic of China Zhu Qingqiao to achieve the agreement and continue with the vaccination days in Mexico.
Unlike vaccines from other laboratories, Sinovac’s vaccine withstands temperatures of up to 25 degrees for several days and neutralizes the 10 strains that cause SARS-CoV-2.
- Antibodies could be induced within 28 days of the first immunization, administering of vaccine dose 14 days apart.
- It produces antibodies that neutralize 10 strains of SARS-CoV-2.
- Clinical trials conducted reported 91.5 percent effectiveness in preventing the disease.
- It does not need a cold chain for transport, endure about 20 days at 25 degrees Celsius.